Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 7—July 2012

Dobrava Hantavirus Infection Complicated by Panhypopituitarism, Istanbul, Turkey, 2010

Nevin Sarıgüzel1Comments to Author , Jörg Hofmann1, Alper Tunga Canpolat, Ali Türk, Jakob Ettinger, Deniz Atmaca, Işın Akyar, Serap Yücel, Ender Arıkan, Yavuz Uyar, Dilek Y. Çağlayık, Ayşe Sesin Kocagöz, Ayşin Kaya, and Detlev H. Kruger
Author affiliations: Acıbadem Hospital, Istanbul, Turkey (N. Sarıgüzel, A.T. Canpolat, D. Atmaca, Serap Yücel, Ender Arıkan); Charité University Medicine, Berlin, Germany (J. Hofmann, J. Ettinger, D.H. Kruger); Labor Berlin Charité-Vivantes GmbH, Berlin (J. Hofmann, J. Ettinger, D. H. Kruger); Acıbadem University, Istanbul (A.Türk, I. Akyar, A. S. Kocagöz); Refik Saydam National Public Health Agency, Ankara, Turkey (Y. Uyar, D. Y. Çağlayık); and University of Geneva, Geneva, Switzerland (A. Kaya)

Main Article

Table 2

Characterization of DOBV hantavirus in a patient’s serum by focus reduction neutralization tests, Istanbul, Turkey, 2010*

Day of hospitalization Focus reduction neutralization test endpoint titer
Puumala hantavirus Hantaan virus DOBV-Aa (strain SK) DOBV-Af (strain Slo)
5 <1:40 <1:40 1:640 1:1,280
26 <1:40 <1:40 1:160 1:320

*DOBV, Dobrava-Belgrade virus; Aa, Apodemus agrarius; Af, Apodemus flavicollis; SK, strain Slovakia; Slo, strain Slovenia.

Main Article

1These authors contributed equally to this article.

Page created: June 12, 2012
Page updated: June 12, 2012
Page reviewed: June 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.